PuSH - Publication Server of Helmholtz Zentrum München

Bornstein, S.R. ; Rubino, F.* ; Ludwig, B. ; Rietzsch, H.* ; Schwarz, P.E. ; Rodionov, R.N.* ; Khunti, K.* ; Hopkins, D.* ; Birkenfeld, A.L. ; Bohm, B.* ; Amiel, S.* ; Holt, R.I.G.* ; Skyler, J.S.* ; deVries, J.H.* ; Renard, E.* ; Eckel, R.H.* ; Zimmet, P.* ; Alberti, K.G.* ; Geloneze, B.* ; Chan, J.C.* ; Mbanya, J.C.* ; Onyegbutulem, H.C.* ; Spinas, G.A.* ; Beuschlein, F.* ; Mingrone, G.*

Consequences of the COVID-19 pandemic for patients with metabolic diseases.

Nat. Metab. 3, 289-292 (2021)
Postprint DOI PMC
Open Access Green
The COVID-19 pandemic has stretched healthcare resources and caused severe knock-on effects on patients with metabolic diseases worldwide. We encourage clinicians and patient-interest groups in the field of diabetes and metabolism to raise their voices to ensure adequate care and admission of patients.
Web of Science
Times Cited
Scopus
Cited By
Altmetric
9
18
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Comment, Opinion
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 2522-5812
e-ISSN 2522-5812
Quellenangaben Volume: 3, Issue: 3, Pages: 289-292 Article Number: , Supplement: ,
Publisher Springer
Publishing Place London
Reviewing status Peer reviewed
Institute(s) Institute of Pancreatic Islet Research (IPI)
Institute of Diabetes Research and Metabolic Diseases (IDM)
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502600-007
G-502600-004
G-502400-001
Scopus ID 85101772537
PubMed ID 33633407
Erfassungsdatum 2021-05-05